180 related articles for article (PubMed ID: 8746629)
1. Purification of recombinant shiga-like toxin type I B subunit.
Austin PR; Hovde CJ
Protein Expr Purif; 1995 Dec; 6(6):771-9. PubMed ID: 8746629
[TBL] [Abstract][Full Text] [Related]
2. Purification of recombinant Shiga-like toxin type I A1 fragment from Escherichia coli.
Zollman TM; Austin PR; Jablonski PE; Hovde CJ
Protein Expr Purif; 1994 Jun; 5(3):291-5. PubMed ID: 7950374
[TBL] [Abstract][Full Text] [Related]
3. Evidence that the A2 fragment of Shiga-like toxin type I is required for holotoxin integrity.
Austin PR; Jablonski PE; Bohach GA; Dunker AK; Hovde CJ
Infect Immun; 1994 May; 62(5):1768-75. PubMed ID: 8168939
[TBL] [Abstract][Full Text] [Related]
4. Identification of three amino acid residues in the B subunit of Shiga toxin and Shiga-like toxin type II that are essential for holotoxin activity.
Perera LP; Samuel JE; Holmes RK; O'Brien AD
J Bacteriol; 1991 Feb; 173(3):1151-60. PubMed ID: 1991714
[TBL] [Abstract][Full Text] [Related]
5. Purification and some properties of a Vero toxin 2 (Shiga-like toxin II) variant (SLT-IIva) of Escherichia coli isolated from infantile diarrhea.
Ohmura M; Cao C; Karasawa T; Okuda J; Kurazono H; Gannon VP; Gyles CL; Takeda Y
Microb Pathog; 1993 Nov; 15(5):399-405. PubMed ID: 8015420
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Shiga-like toxin I B-subunit expression and localization in Escherichia coli and Vibrio cholerae by using trc or iron-regulated promoter systems.
Acheson DW; Calderwood SB; Boyko SA; Lincicome LL; Kane AV; Donohue-Rolfe A; Keusch GT
Infect Immun; 1993 Mar; 61(3):1098-104. PubMed ID: 8432592
[TBL] [Abstract][Full Text] [Related]
7. Association of enterohemolysin and non-fermentation of rhamnose and sucrose with Shiga-like toxin genes in Escherichia coli from calves.
Wieler LH; Bauerfeind R; Weiss R; Pirro F; Baljer G
Zentralbl Bakteriol; 1995 Apr; 282(3):265-74. PubMed ID: 7549158
[TBL] [Abstract][Full Text] [Related]
8. One step high yield affinity purification of shiga-like toxin II variants and quantitation using enzyme linked immunosorbent assays.
Acheson DW; Jacewicz M; Kane AV; Donohue-Rolfe A; Keusch GT
Microb Pathog; 1993 Jan; 14(1):57-66. PubMed ID: 8321118
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Shiga-like toxin I B subunit purified from overproducing clones of the SLT-I B cistron.
Ramotar K; Boyd B; Tyrrell G; Gariepy J; Lingwood C; Brunton J
Biochem J; 1990 Dec; 272(3):805-11. PubMed ID: 2268304
[TBL] [Abstract][Full Text] [Related]
10. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3.
Ling H; Boodhoo A; Hazes B; Cummings MD; Armstrong GD; Brunton JL; Read RJ
Biochemistry; 1998 Feb; 37(7):1777-88. PubMed ID: 9485303
[TBL] [Abstract][Full Text] [Related]
11. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands.
Kitov PI; Sadowska JM; Mulvey G; Armstrong GD; Ling H; Pannu NS; Read RJ; Bundle DR
Nature; 2000 Feb; 403(6770):669-72. PubMed ID: 10688205
[TBL] [Abstract][Full Text] [Related]
12. Escherichia coli cytotoxins and enterotoxins.
Gyles CL
Can J Microbiol; 1992 Jul; 38(7):734-46. PubMed ID: 1393838
[TBL] [Abstract][Full Text] [Related]
13. Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2).
Oku Y; Yutsudo T; Hirayama T; O'Brien AD; Takeda Y
Microb Pathog; 1989 Feb; 6(2):113-22. PubMed ID: 2654533
[TBL] [Abstract][Full Text] [Related]
14. Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine.
Weinstein DL; Jackson MP; Samuel JE; Holmes RK; O'Brien AD
J Bacteriol; 1988 Sep; 170(9):4223-30. PubMed ID: 3045088
[TBL] [Abstract][Full Text] [Related]
15. Binding of Escherichia coli verotoxins to cell surface protein on wild-type and globotriaosylceramide-deficient Vero cells.
Devenish J; Gyles C; LaMarre J
Can J Microbiol; 1998 Jan; 44(1):28-34. PubMed ID: 9522446
[TBL] [Abstract][Full Text] [Related]
16. In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity.
Weinstein DL; Jackson MP; Perera LP; Holmes RK; O'Brien AD
Infect Immun; 1989 Dec; 57(12):3743-50. PubMed ID: 2807546
[TBL] [Abstract][Full Text] [Related]
17. Binding of avian ovomucoid to shiga-like toxin type 1 and its utilization for receptor analog affinity chromatography.
Miyake M; Utsuno E; Noda M
Anal Biochem; 2000 Jun; 281(2):202-8. PubMed ID: 10870836
[TBL] [Abstract][Full Text] [Related]
18. Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies.
Downes FP; Barrett TJ; Green JH; Aloisio CH; Spika JS; Strockbine NA; Wachsmuth IK
Infect Immun; 1988 Aug; 56(8):1926-33. PubMed ID: 3294179
[TBL] [Abstract][Full Text] [Related]
19. A system for production and rapid purification of large amounts of the Shiga toxin/Shiga-like toxin I B subunit.
Calderwood SB; Acheson DW; Goldberg MB; Boyko SA; Donohue-Rolfe A
Infect Immun; 1990 Sep; 58(9):2977-82. PubMed ID: 2201641
[TBL] [Abstract][Full Text] [Related]
20. Expression and purification of Shiga-like toxin II B subunits.
Acheson DW; De Breucker SA; Jacewicz M; Lincicome LL; Donohue-Rolfe A; Kane AV; Keusch GT
Infect Immun; 1995 Jan; 63(1):301-8. PubMed ID: 7806370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
